


Results from Belimumab Safety Study

Researchers Test Belimumab in Scleroderma
Subcutaneous Belimumab Improves Systemic Lupus Srythematosus Outcomes

The FDA Approved Several New Rheumatology Drugs in 2017

European Commission Approves Subcutaneous Belimumab for SLE; FDA Safety Alert for Febuxostat

OA Knee Pain Treatment Enters Clinical Trials, Ixekizumab Receives FDA Approval & Belimumab Promising for SLE Patients

Oxycodone Capsules Put on Hold; Clinical Trials for Lupus Nephritis & SLE Therapies
